SomaGenics is an early-stage biotech company developing novel RNA-based therapeutics and diagnostics. Current areas of therapeutic development include hepatitis C, psoriasis, and HIV.  SomaGenics has an outstanding record of attracting grant funding for its cutting-edge R&D in RNA. SomaGenics Inc. 2161 Delaware Avenue Santa Cruz, CA 95060 Tel: (831) 426-7700 | Fax: (831) 420-0685